title: Activation of myocardial phosphoinositide-3-kinase p110α ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis.
abstract: Phosphoinositide-3-kinase (PI3K)/Akt dependent signaling has been shown to improve outcome in sepsis/septic shock. There is also ample evidence that PI3K/Akt dependent signaling plays a crucial role in maintaining normal cardiac function. We hypothesized that PI3K/Akt signaling may ameliorate septic shock by attenuating sepsis-induced cardiac dysfunction. Cardiac function and survival were evaluated in transgenic mice with cardiac myocyte specific expression of constitutively active PI3K isoform, p110α (caPI3K Tg). caPI3K Tg and wild type (WT) mice were subjected to cecal ligation/puncture (CLP) induced sepsis. Wild type CLP mice showed dramatic cardiac dysfunction at 6 hrs. Septic cardiomyopathy was significantly attenuated in caPI3K CLP mice. The time to 100% mortality was 46 hrs in WT CLP mice. In contrast, 80% of the caPI3K mice survived at 46 hrs after CLP (p<0.01) and 50% survived >30 days (p<0.01). Cardiac caPI3K expression prevented expression of an inflammatory phenotype in CLP sepsis. Organ neutrophil infiltration and lung apoptosis were also effectively inhibited by cardiac PI3k p110α expression. Cardiac high mobility group box-1 (HMGB-1) translocation was also inhibited by caPI3K p110α expression. We conclude that cardiac specific activation of PI3k/Akt dependent signaling can significantly modify the morbidity and mortality associated with sepsis. Our data also indicate that myocardial function/dysfunction plays a prominent role in the pathogenesis of sepsis and that maintenance of cardiac function during sepsis is essential. Finally, these data suggest that modulation of the PI3K/p110α signaling pathway may be beneficial in the prevention and/or management of septic cardiomyopathy and septic shock.
authors.affiliation: Department of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee, United States of America.
authors.forename: Chuanfu
authors.initials: C
authors.lastname: Li
authors.forename: Fang
authors.initials: F
authors.lastname: Hua
authors.forename: Tuanzhu
authors.initials: T
authors.lastname: Ha
authors.forename: Krishna
authors.initials: K
authors.lastname: Singh
authors.forename: Chen
authors.initials: C
authors.lastname: Lu
authors.forename: John
authors.initials: J
authors.lastname: Kalbfleisch
authors.forename: Kevin F
authors.initials: KF
authors.lastname: Breuel
authors.forename: Tiffany
authors.initials: T
authors.lastname: Ford
authors.forename: Race L
authors.initials: RL
authors.lastname: Kao
authors.forename: Ming
authors.initials: M
authors.lastname: Gao
authors.forename: Tammy R
authors.initials: TR
authors.lastname: Ozment
authors.forename: David L
authors.initials: DL
authors.lastname: Williams
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000502:physiology; D015153:Blotting, Western; D016207:Cytokines / Q000097:blood; D004452:Echocardiography; D006439:Hemodynamics / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D009206:Myocardium / Q000201:enzymology*; D009195:Peroxidase / Q000378:metabolism; D058539:Phosphatidylinositol 3-Kinase / Q000235:genetics / Q000378:metabolism*; D018805:Sepsis / Q000201:enzymology* / Q000382:microbiology / Q000628:therapy*
chemical_list: D016207:Cytokines; D009195:Peroxidase; D058539:Phosphatidylinositol 3-Kinase